University of Minnesota. Driven to Discover.
The strain has 2 mutations that might alter its susceptibility to the neuraminidase inhibitor class of antiviral drugs.
In addition to widespread H5N8, H5N1 is confirmed in Nigeria and H5N6 in Japan.
Meanwhile, many countries across Europe and Asia continue to battle outbreaks of several strains.
Some have theorized about changes in the virus, but preliminary data show no mutations so far.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.